Montpeliers Boosts Growth with Force24's Marketing Automation
Montpeliers, a prominent hospitality group in Scotland, has invested in Force24's marketing automation platform to drive growth and enhance customer communication. The group, which includes distinct venues catering to a diverse audience, aims for a 10% increase in customers over the next three years.
Montpeliers, with a current customer base of 90,000, seeks to gain deeper insights into its clientele for personalized communication. The group has chosen Force24, a leading UK-based marketing automation platform, to achieve this. Force24 boasts impressive technological capabilities and is praised by Montpeliers' development director David Johnston for its affordability and ease of use.
Force24 has a strong track record in the travel and tourism sector, counting significant customers such as Tourism Ireland, British Airways, and Scottish Tourism Alliance. The platform aims to help Montpeliers increase market visibility, database size, referral numbers, engagement, and ultimately, customer satisfaction. With Force24's UK headquarters providing excellent training, support, and quick response times, Montpeliers is well-equipped to achieve its growth targets.
Montpeliers' investment in Force24's marketing automation platform signals a strategic move to enhance customer communication and drive growth. With Force24's proven capabilities in the tourism industry and its commitment to GDPR compliance, Montpeliers anticipates increased market visibility, a larger customer base, and improved satisfaction, all contributing to its ambitious 10% growth target over the next three years.
Read also:
- Urgent investment: Province funds 5.3 million dollars for expanding primary care in Elgin-Middlesex-London area
- Federal Environmental Protection Agency under scrutiny for alleged manipulation of soil sample results following East Palestine catastrophe
- Colon Cancer Genetic Testing: Insights into its Function, Application, and Additional Details
- RFK Jr. Takes Bold Step in Vaccine Research Development, Possibly Poseing a Threat to Public Safety
